SOPATMEDVR1: VR as a Facilitator for Participation in Society Among Persons With MHD/SUD

Sponsor
Sykehuset Innlandet HF (Other)
Overall Status
Recruiting
CT.gov ID
NCT05653167
Collaborator
Inland Norway University of Applied Sciences (Other)
124
1
35.1
3.5

Study Details

Study Description

Brief Summary

This study is the first part of a larger project called "Virtual Reality (VR) as a facilitator for participation in society among persons with mental health/substance use disorders" in which aims to explore,develop and evaluate a VR-based paradigm that facilitates social participation and promotes social recovery of individuals with mental health and/or substance use disorders (MHD/SUD). The overall project comprises three work packages: an exploration study, a development study, and an evaluation study. This study will make up work package 1. The primary aim of this study (WP1) is to explore facilitators and barriers for participation in society among person with MHD/SUD, and to provide an understanding of mechanisms of social participation and social cohesion among persons with MHD/ SUD that may be affected by VR-based interventions. The investigators will derive a socio-emotional learning domain to facilitate key interpersonal and social processes among persons with MHD/SUD in VR-based interventions. To achieve the purpose of this study, the invistigators conduct 10 indepth interviews with service-user with MHD/SUD, 2 focus group interviews with 14 service-providers and an interview-survey with 100 service users. This gives the investigators the possibility to explore facilitators and barriers for social participation as experienced as by individuals with MHD/SUD and identify key interpersonal and social processes suitable to be addressed by tailored VR based interventions.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    124 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Complex Socio-emotional Learning in VR-based Simulation Training Among Persons With Mental Health and/or Substance Use Disorders"
    Actual Study Start Date :
    Mar 1, 2022
    Anticipated Primary Completion Date :
    Aug 1, 2023
    Anticipated Study Completion Date :
    Feb 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Practical and social functioning [2 hours]

      measured by the Practical and Social Functioning Scale (PSF)

    2. Social inclusion [2 hours]

      Measured by the Social and Community Opportunities Profile (SCOPE)

    3. Barriers for participation in society [duration of the in-depth interview]

      This will be assessed within in-depth interviews

    4. Facilitators for participation in society [duration of the in-depth interview]

      This will be assessed within in-depth interviews

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • above 18 years of age

    • receiving services in the municipality due to mental health and or addiction problems.

    Exclusion Criteria:

    -visual and hearing impairment, neurological disorders, and mental retardation [score ≤70 on the Test of Intelligence].

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Innlandet Hospital Trust Brumunddal Norway 2381

    Sponsors and Collaborators

    • Sykehuset Innlandet HF
    • Inland Norway University of Applied Sciences

    Investigators

    • Principal Investigator: Lars Lien, MD, Ph.d, Sykehuset Innlandet HF

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Sykehuset Innlandet HF
    ClinicalTrials.gov Identifier:
    NCT05653167
    Other Study ID Numbers:
    • 326773VR_WP1
    First Posted:
    Dec 16, 2022
    Last Update Posted:
    Dec 16, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 16, 2022